Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal.
暂无分享,去创建一个
A. Schuchat | S. Dowell | H. Jha | T. Lietman | J. Elliott | B. Gaynor | A. Fry | T. Hyde | J. Elliott | R. Bhatta | T. Lietman | J. Chaudhary | T. Hyde
[1] M. Cetron,et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. , 2000, The New England journal of medicine.
[2] C. Whitty,et al. Impact of community-based mass treatment for trachoma with oral azithromycin on general morbidity in Gambian children. , 1999, The Pediatric infectious disease journal.
[3] H. Gilles,et al. The conquest of 'river blindness'. , 1991, Annals of tropical medicine and parasitology.
[4] G. Johnson,et al. Operational comparison of single-dose azithromycin and topical tetracycline for trachoma. , 2000, Investigative ophthalmology & visual science.
[5] H. Jha,et al. Comparison of two azithromycin distribution strategies for controlling trachoma in Nepal. , 2001, Bulletin of the World Health Organization.
[6] H. Whittle,et al. Randomised controlled trial of single-dose azithromycin in treatment of trachoma , 1993, The Lancet.
[7] K. Tabbara,et al. Single-dose azithromycin in the treatment of trachoma. A randomized, controlled study. , 1996, Ophthalmology.
[8] J. Mathews,et al. A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] S. Block,et al. Future indications for macrolides. , 1997, The Pediatric infectious disease journal.
[10] Susan R. Johnson,et al. Macrolide Resistance among Invasive Streptococcus Pneumoniae Isolates , 2022 .
[11] M. Ferraro. Performance standards for antimicrobial susceptibility testing , 2001 .
[12] M. Leinonen,et al. Weekly oral azithromycin as prophylaxis for agents causing acute respiratory disease. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] R. Adegbola,et al. Effect of azithromycin on pharyngeal microflora. , 1995, The Pediatric infectious disease journal.
[14] R. J. Thomas,et al. Penicillin prophylaxis for streptococcal infections in United States Navy and Marine Corps recruit camps, 1951-1985. , 1988, Reviews of infectious diseases.
[15] P Huovinen,et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. , 1997, The New England journal of medicine.
[16] R. Rubinstein,et al. A comparison of oral azithromycin with topical oxytetracycline/polymyxin for the treatment of trachoma in children. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] J. Whitcher,et al. Alterations in the conjunctival bacterial flora following a single dose of azithromycin in a trachoma endemic area , 1999, The British journal of ophthalmology.
[18] B. Greene,et al. Community-based treatment of onchocerciasis with ivermectin: safety, efficacy, and acceptability of yearly treatment. , 1991, The Journal of infectious diseases.
[19] M. Tarlow. Laboratory, clinic and community: the logistics of liaison. , 1997, The Pediatric infectious disease journal.
[20] A D Négrel,et al. Global data on blindness. , 1995, Bulletin of the World Health Organization.
[21] S. Cairncross,et al. Review of the evidence base for the ‘F’ and ‘E’ components of the SAFE strategy for trachoma control , 2000, Tropical medicine & international health : TM & IH.
[22] George M. Carlone,et al. Evaluation of a Medium (STGG) for Transport and Optimal Recovery of Streptococcus pneumoniae from Nasopharyngeal Secretions Collected during Field Studies , 2001, Journal of Clinical Microbiology.
[23] R. Wong,et al. Acute infectious diarrhea. , 1993, The Medical clinics of North America.
[24] T. Quinn,et al. Azithromycin in control of trachoma , 1999, The Lancet.
[25] T. Adam,et al. Integrated management of the sick child. , 1995, Bulletin of the World Health Organization.
[26] S. Schrag,et al. Limiting the spread of resistant pneumococci: biological and epidemiologic evidence for the effectiveness of alternative interventions. , 2000, Clinical microbiology reviews.
[27] G. Burnham. Adverse reactions to ivermectin treatment for onchocerciasis. Results of a placebo-controlled, double-blind trial in Malawi. , 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene.